Cynata has manufacturing solution for new covd treatments, page-34

@Bazsa, although things are moving with very fast in this sector, I doubt that it went from "two to three donors for a large trial" to "one donor to save the life of thousands" within less than three years:


https://www.biocentury.com/bc-innovations/product-rd/2017-07-20/cynata-preps-take-first-ips-cell-derived-mscs-clinic

Besides, your latest post on here sounded very familiar and finally this morning I remembered where:

December 21, 2005:

http://investor.osiris.com/news-releases/news-release-details/osiris-stem-cell-funding-totals-70-million-2005

And we all know what happened a few years or should I say a few unsuccessful P3 clinical trials later?

I would therefore suggest to stick to facts and also quote your sources, to allow people to differentiate between a silly ramp and a researched post.